SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994; 37: 12839.
  • 2
    Griedinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998; 114: 8017.
  • 3
    Medsger TA Jr, Steen VD. Classification, prognosis. In: ClementsPJ, FurstDE, editors. Systemic sclerosis. Baltimore: Williams & Wilkins; 1996. p. 5164.
  • 4
    White B, Moore WC, Wigley FM, Xiao HQ, Wise RA. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 94754.
  • 5
    Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990; 88: 4706.
  • 6
    Saito Y, Terada M, Takada T, Ishida T, Moriyama H, Ooi H, et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002; 26: 34957.
  • 7
    Kane GC, Varga J, Conant EF, Spirn PW, Jimenez S, Fish JE. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status. Respir Med 1996; 90: 22330.
  • 8
    Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 31928.
  • 9
    Chapman HA. A Fas pathway to pulmonary fibrosis. J Clin Invest 1999; 104: 12.
  • 10
    Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001; 99: 30819.
  • 11
    Bitterman PD, Wendt CH. The pathogenesis of pulmonary fibrosis. In: FishmanAP, editor. Fishman's pulmonary diseases and disorders. New York: McGraw-Hill; 1998. p. 347358.
  • 12
    Kuhn C III, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140: 1693703.
  • 13
    Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, et al. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999; 104: 139.
  • 14
    Westermann W, Schobl R, Rieber EP, Frank KH. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol 1999; 75: 62938.
  • 15
    Suzuki N, Ohta K, Horiuchi T, Takizawa H, Ueda T, Kuwabara M, et al. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax 1996; 51: 103642.
  • 16
    Hu H, Stein-Streilein J. Hapten-immune pulmonary interstitial fibrosis (HIPIF) in mice requires both CD4+ and CD8+ T lymphocytes. J Leukoc Biol 1993; 54: 41422.
  • 17
    Sharma SK, MacLean JA, Pinto C, Kradin RL. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am J Respir Crit Care Med 1996; 154: 193200.
  • 18
    Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989; 170: 65563.
  • 19
    Okazaki T, Nakao A, Nakano H, Takahashi F, Takahashi K, Shimozato O, et al. Impairment of bleomycin-induced pulmonary fibrosis in CD28-deficient mice. J Immunol 2001; 167: 197781.
  • 20
    Helene M, Lake-Bullock V, Zhu J, Hao H, Cohen DA, Kaplan AM. T cell independence of bleomycin-induced pulmonary fibrosis. J Leukoc Biol 1999; 65: 18795.
  • 21
    Janick-Buckner D, Ranges GE, Hacker MP. Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J mice. Toxicol Appl Pharmacol 1989; 100: 47484.
  • 22
    Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 1979; 120: 8939.
  • 23
    Christensen PJ, Goodman RE, Pastoriza L, Moore B, Toews GB. Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. Am J Pathol 1999; 155: 17739.
  • 24
    Denis M, Cormier Y, Laviolette M, Ghadirian E. T cells in hypersensitivity pneumonitis: effects of in vivo depletion of T cells in a mouse model. Am J Respir Cell Mol Biol 1992; 6: 1839.
  • 25
    Fireman E, Vardinon N, Burke M, Spizer S, Levin S, Endler A, et al. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 1998; 11: 70611.
  • 26
    Leblond V, Zouabi H, Sutton L, Guillon JM, Mayaud CM, Similowski T, et al. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease. Am J Respir Crit Care Med 1994; 150: 105661.
  • 27
    Agostini C, Trentin L, Sancetta R, Facco M, Tassinari C, Cerutti A, et al. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood 1997; 90: 111523.
  • 28
    Yamadori I, Fujita J, Kajitani H, Bandoh S, Tokuda M, Yang Y, et al. Lymphocyte subsets in lung tissues of non-specific interstitial pneumonia and pulmonary fibrosis associated with collagen vascular disorders: correlation with CD4/CD8 ratio in bronchoalveolar lavage. Lung 2000; 178: 36170.
  • 29
    Yurovsky VY, Wigley FM, Wise RA, White B. Skewing of the CD8+ T cell repertoire in the lungs of systemic sclerosis patients. Human Immunol 1996; 48: 8497.
  • 30
    Atamas SP, Yurovsky VY, Wise R, Wigley FM, Robinson CJG, Henry P, et al. Type 2 cytokines made by CD8+ lung cells predict decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999; 42: 116878.
  • 31
    Postlethwaite AE, Seyer JM. Fibroblast chemotaxis induced by human recombinant interleukin-4: identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest 1991; 87: 214752.
  • 32
    Feghali CA, Bost KL, Boulware DW, Levy LS. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol 1992; 63: 1827.
  • 33
    Birkland TP, Cheavens MD, Pincus SH. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Dermatol Res 1994; 286: 3128.
  • 34
    Duncan MR, Berman B. Gamma interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985; 162: 51627.
  • 35
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 58190.
  • 36
    Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 511621.
  • 37
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 148638.
  • 38
    Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 2000; 46: 6981.
  • 39
    Giordano M. Classification of progressive systemic sclerosis (scleroderma). In: BlackCM, MyersAR, editors. Systemic sclerosis (scleroderma). New York: Gower; 1985. p. 21.
  • 40
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 2025.
  • 41
    Bott CM, Doshi JB, Morimoto C, Romain PL, Fox DA. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. Int Immunol 1993; 5: 78392.
  • 42
    Morel Y, Schiano de Colella JM, Harrop J, Deen KC, Holmes SD, Wattam TA, et al. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 2000; 165: 4397404.
  • 43
    Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, et al. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 2000; 15: 33145.
  • 44
    Bismuth G, Boumsell L. Controlling the immune system through semaphorins. Sci STKE 2002; 2002(128): RE4.
  • 45
    D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998; 161: 51115.
  • 46
    Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2001; 97: 3335.
  • 47
    Gauchat JF, Schlagenhauf E, Feng NP, Moser R, Yamage M, Jeannin P, et al. A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 1997; 27: 9718.
  • 48
    Novelli F, D'Elios MM, Bernabei P, Ozmen L, Rigamonti L, Almerigogna F, et al. Expression and role in apoptosis of the α- and β-chains of the IFN-γ receptor on human Th1 and Th2 clones. J Immunol 1997; 159: 20613.
  • 49
    Odum N, Bregenholt S, Eriksen KW, Skov S, Ryder LP, Bendtzen K, et al. The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells. Tissue Antigens 1999; 54: 5727.
  • 50
    Wang HC, Klein JR. Multiple levels of activation of murine CD8+ intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-γ, and IL-10 regulation. J Immunol 2001; 167: 671723.
  • 51
    Gramaglia I, Mauri DN, Miner KT, Ware CF, Croft M. Lymphotoxin αβ is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J Immunol 1999; 162: 13338.
  • 52
    Josien R, Wong BR, Li HL, Steinman RM, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999; 162: 25628.
  • 53
    Chan WL, Pejnovic N, Lee CA, Al-Ali NA. Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes. J Immunol 2001; 167: 123844.
  • 54
    Smeltz RB, Chen J, Ehrhardt R, Shevach EM. Role of IFN-γ in Th1 differentiation: IFN-γ regulates IL-18Rα expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor β2 expression. J Immunol 2002; 168: 616572.
  • 55
    Wendling U, Walczak H, Dorr J, Jaboci C, Weller M, Krammer PH, et al. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells. Cell Death Differ 2000; 7: 63744.
  • 56
    Teh HS, Seebaran A, Teh SJ. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death. J Immunol 2000; 165: 481421.
  • 57
    Agostini C, Zambello R, Sancetta R, Cerutti A, Milani A, Tassinari C, et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996; 153: 135967.
  • 58
    Agostini C, Zambello R, Trentin L, Cerutti A, Enthammer C, Facco M, et al. Expression of TNF receptors by T cells and membrane TNF-α by alveolar macrophages suggests a role for TNF-α in the regulation of the local immune responses in the lung of HIV-1-infected patients. J Immunol 1995; 154: 292838.
  • 59
    Muta H, Boise LH, Fang L, Podack ER. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol 2000; 165: 510511.
  • 60
    Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195: 15418.
  • 61
    Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001; 7: 1148.
  • 62
    Grant S, Qiao L, Dent P. Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Front Biosci 2002; 7: d37689.
  • 63
    Brown TJ, Lioubin MN, Marquardt H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes: synergistic antiproliferative activity of transforming growth factor β1, interferon-γ, and oncostatin M for human melanoma cells. J Immunol 1987; 139: 297783.
  • 64
    Scaffidi AK, Mutsaers SE, Moodley YP, McAnulty RJ, Laurent GJ, Thompson PJ. Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol 2002; 136: 793801.
  • 65
    Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000; 149: 130923.
  • 66
    Van Wely CA, Beverley PC, Brett SJ, Britten CJ, Tite JP. Expression of L-selectin on Th1 cells is regulated by IL-12. J Immunol 1999; 163: 121421.
  • 67
    Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 1992; 176: 24553.
  • 68
    Roberts AI, Brolin RE, Ebert EC. Integrin α1β1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen. Immunology 1999; 97: 67985.
  • 69
    Erle DJ, Brown T, Christian D, Aris R. Lung epithelial lining fluid T cell subsets defined by distinct patterns of β7 and β1 integrin expression. Am J Respir Cell Mol Biol 1994; 10: 23744.
  • 70
    Lefrancois L, Parker CM, Olson S, Muller W, Wagner N, Schon MP, et al. The role of β7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med 1999; 189: 16318.
  • 71
    Feng CG, Britton WJ, Palendira U, Groat NL, Briscoe H, Bean AG. Up-regulation of VCAM-1 and differential expansion of β integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol 2000; 164: 485360.
  • 72
    Masopust D, Jiang J, Shen H, Lefrancois L. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol 2001; 166: 234856.
  • 73
    Lohmeyer J, Friedrich J, Grimminger F, Maus U, Tenter R, Morr H, et al. Expression of mucosa-related integrin αEβ7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol 1999; 116: 3406.
  • 74
    Braun RK, Sterner-Kock A, Kilshaw PJ, Ferrick DA, Giri SN. Integrin αEβ7 expression on BAL CD4+, CD8+, and γδ T-cells in bleomycin-induced lung fibrosis in mouse. Eur Respir J 1996; 9: 6739.
  • 75
    Rihs S, Walker C, Virchow JC Jr, Boer C, Kroegel C, Giri SN, et al. Differential expression of αEβ7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by α4β1-integrin crosslinking and TGF-β. Am J Respir Cell Mol Biol 1996; 15: 60010.
  • 76
    Sheppard D. Integrin-mediated activation of transforming growth factor-β1 in pulmonary fibrosis. Chest 2001; 120 Suppl 1: 49S53S.
  • 77
    Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med 2002; 196: 16371.
  • 78
    Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999; 65: 25.
  • 79
    Strelau J, Bottner M, Lingor P, Suter-Crazzolara C, Galter D, Jaszai J, et al. GDF-15/MIC-1 a novel member of the TGF-β superfamily. J Neural Transm Suppl 2000; 60: 2736.
  • 80
    Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 2002; 13: 7585.
  • 81
    Iwata S, Ohashi Y, Kamiguchi K, Morimoto C. Beta 1-integrin-mediated cell signaling in T lymphocytes. J Dermatol Sci 2000; 23: 7586.
  • 82
    McGaha T, Saito S, Phelps RG, Gordon R, Noben-Trauth N, Paul WE, et al. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4Rα and transforming growth factor-β genes. J Invest Dermatol 2001; 116: 13643.
  • 83
    Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000; 204: 1928.
  • 84
    Politz O, Kodelja V, Guillot P, Orfanos CE, Goerdt S. Pseudoexons and regulatory elements in the genomic sequence of the β-chemokine, alternative macrophage activation-associated CC-chemokine (AMAC)-1. Cytokine 2000; 12: 1206.
  • 85
    Atamas SP, Luzina IG, Choi J, Tsymbalyuk N, White B. Pulmonary and activation-regulated chemokine (PARC) stimulates tyrosine phosphorylation, activation of Sp1, Smad 3/4 and c-Myb, and production of collagen in lung fibroblasts [abstract]. Arthritis Rheum 2002; 46 Suppl 9: S382.
  • 86
    Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 2002; 26: 54957.
  • 87
    Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 2000; 95: 23140.
  • 88
    Carter LL, Zhang X, Dubey C, Rogers P, Tsui L, Swain SL. Regulation of T cell subsets from naive to memory. J Immunother 1998; 21: 1817.
  • 89
    Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 1998; 8: 17986.